South Bow Quote - SOBO | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NYSE
South Bow Corporation (SOBO) Share Price

South Bow Corporation (SOBO)

23.49

-0.75

(-3.09%)

Closed 29 December 8:00AM

Delayed by 15 minutes

23.60

0.11

(0.47%)

After Hours: 10:55AM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

23.60

Bid

-

Offer

-

Volume

4,620,742

23.28 Day's Range 24.17

21.98 52 Week Range 27.30

Previous Close

24.24

Open

24.05

Last Trade

Last Trade Time

Average Volume (3m)

825,667

Financial Volume

US$ 108,748,927

VWAP

23.5349

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

South Bow Declares Inaugural Dividend of U.S.$0.50 per Share

CALGARY, Alberta, Nov. 07, 2024 (GLOBE NEWSWIRE) -- South Bow Corp. (TSX & NYSE: SOBO) (South Bow) announces that its board of directors has declared South Bow’s inaugural quarterly dividend...

South Bow Recommends Shareholders Reject TRC Capital's Below-market "Mini-tender" Offer

CALGARY, Alberta, Nov. 01, 2024 (GLOBE NEWSWIRE) -- South Bow Corp. (TSX & NYSE: SOBO) has received an unsolicited "mini-tender" offer from TRC Capital Investment Corp. (TRC Capital) to...

Form S-8 - Securities to be offered to employees in employee benefit plans

South Bow Corporation Launches as Independent Company

CALGARY, Alberta, Oct. 01, 2024 (GLOBE NEWSWIRE) -- South Bow Corporation (South Bow) is launching as an independent company after completing its planned separation from TC Energy Corporation...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.2296	0.982439324958	23.3704	24.25	23.06	581264	23.80886888	CS
4	-1.88	-7.37833594976	25.48	26.28	22.75	799271	24.39564013	CS
12	1.4038	6.32450599652	22.1962	27.3	21.98	825667	24.33509737	CS
26	1.4038	6.32450599652	22.1962	27.3	21.98	825667	24.33509737	CS
52	1.4038	6.32450599652	22.1962	27.3	21.98	825667	24.33509737	CS
156	1.4038	6.32450599652	22.1962	27.3	21.98	825667	24.33509737	CS
260	1.4038	6.32450599652	22.1962	27.3	21.98	825667	24.33509737	CS

SOBO - Frequently Asked Questions (FAQ)

What is the current South Bow share price?

The current share price of South Bow is US$ 23.60

What is the 1 year trading range for South Bow share price?

South Bow has traded in the range of US$ 21.98 to US$ 27.30 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SESSES AI Corporation	US$ 2.42 (70.42%)	114.92M
STEMStem Inc	US$ 0.5906 (43.21%)	48.31M
MPLNChurchill Capital Corp III	US$ 17.42 (38.69%)	699.46k
EVTLVertical Aerospace Ltd	US$ 15.50 (32.14%)	1.05M
KOREKORE Group Holdings Inc	US$ 2.4016 (26.40%)	598.42k
TWNTaiwan Fund Inc	US$ 38.59 (-17.40%)	58.74k
ENFYEnlightify Inc	US$ 0.9901 (-13.90%)	150.8k
LMNDLemonade Inc	US$ 39.46 (-10.64%)	3.23M
SMRNuScale Power Corporation	US$ 19.5043 (-10.61%)	9.95M
CLPRClipper Realty Inc	US$ 4.63 (-10.10%)	218.58k
QBTSD Wave Quantum Inc	US$ 9.8827 (-0.17%)	115.54M
SESSES AI Corporation	US$ 2.42 (70.42%)	114.92M
BBAIBigBear ai Holdings Inc	US$ 4.22 (-5.17%)	65.4M
ABEVAmbev SA	US$ 1.875 (-0.79%)	61.05M
FFord Motor Company	US$ 10.04 (-0.30%)	52.19M

EmpressMonk25

EmpressMonk25 3 minutes ago

A valuation of $100 million suggests a narrative of success; therefore, given the nature of the patent for moving money, the actual value is far greater, reaching unprecedented levels. This patent appears to be revolutionary in the same way XRP seeks to move money. XRP method (same as patent describ

vuletini

vuletini 4 minutes ago

Patrick Bateman

Patrick Bateman 4 minutes ago

Why should it be .0008 rather than .0005

vuletini

vuletini 5 minutes ago

Nothing to get excited about....drop in the bucket

wingtrade

wingtrade 6 minutes ago

I doubt anybody could even sell $10K of stock at .0001 before there would be no bid on this

RUSTYJ

RUSTYJ 7 minutes ago

Learned my lesson years ago on this one

CherryTree1

CherryTree1 7 minutes ago

One would hope that once DCVAX-L for GBM is approved that Phase-3 trials for Direct would be much faster since we now know how the immune systems is engages with DCVAX-L. We shouldn't have to wait to see the long tail response over 5 or 6 years but could measure immune system cell response early on

NASDAQ2020

NASDAQ2020 8 minutes ago

This press release has the market size for Concerta in 2020:

https://health.economictimes.indiatimes.com/news/pharma/dr-reddys-launches-generic-concerta-in-us-market/77906832

TheConcertabrand and generic market had U.S. sales of approximately USD $1.159 Billion

TenKay

TenKay 8 minutes ago

Well the original TSNP/Humbl deal left the legacy shareholders with 15% of the company equity after the Pref B were issued.

That dropped to less than 2% with the convertible debt dilution.

Foote is just going back to what he knows.

And nobody can actually

RobotDroid

RobotDroid 9 minutes ago

Not true, nwbo could have submitted a flawed document that has slowed approval to a crawl. Knowing how inept they are, it's a possibility.

dinogreeves

dinogreeves 11 minutes ago

It's not a gamble if you think SMCI will have filings in by February 25th.

skitahoe

skitahoe 11 minutes ago

I agree, and in the Q&A it's possible something new may come up, but much of the time the answer will be something like, it's too early for us to discuss this at this time.

When certain questions are answered I've often suspected that Analysts were specifically given suggestions on qu

wingtrade

wingtrade 11 minutes ago

This is a disaster lol

Hardazoak

Hardazoak 12 minutes ago

3 high grade gold mines acquired and paid for in full, 1 joint venture gold-silver mine that is currently in production and generating millions of dollars in revenue every quarter, 1 stockpile agreement worth 1.5 billion dollars signed and sealed, 1 top of the line massive labratory, 1 plant built t

SSKILLZ1

SSKILLZ1 12 minutes ago

Savvy Pick 10 Contest #1 Results In (Week 26)

Hope everyone enjoys the stats. Below is the link to the board. Have a great weekend everyone.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-1-43057

SSKILLZ1

SSKILLZ1 12 minutes ago

Savvy Pick 10 Contest #1 Results In (Week 26)

Hope everyone enjoys the stats. Below is the link to the board. Have a great weekend everyone.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-1-43057

dennisdave

dennisdave 13 minutes ago

Getting trials going will be critical to their ability to raise capital over the upcoming years as the -L MHRA story fades into the rear view mirror.
Your claim that NWBO could continue after DCVAXL has not been approved in the UK is BS, they cant it will end them guaranteed.

ronle

ronle 13 minutes ago

Thank you very much.

Huggy Bear

Huggy Bear 16 minutes ago

Shareholders are being raked over the coals, and not only are they totally unaware of what they really own, they are actually giddy about being fleeced.

With a little help from the usual suspects, of course.

Bull_Dolphin

Bull_Dolphin 16 minutes ago

This is a grown man? LOL

Large Green

Large Green 17 minutes ago

NDT, if this eight trillion was actually negative to JPM, their stock would have plummeted long before the filing was made public.

There is more to this however, there could be monies obfuscated of this huge amount that may find its way to those who signed timely releases by 3/2012.

SSKILLZ1

SSKILLZ1 18 minutes ago

Savvy Pick 10 Contest #1 (Week 26)

Congrats to our current leader LARRYBAZ up 85.49% so far in the contest. There are 23/27 portfolio up in the contest or 85.19%. So without any further ado the info. is below.
[pre]
Alias % Gain/Loss
1 LARRYB

Konaploinks

Konaploinks 18 minutes ago

You’re right. I’m thinking around 400 something , soon. If we don’t get taken over before that. Nvda ran to over 1,000 very quickly. Ionq has the patents Nvda needs to progress further. Also Msft. IBM. Google AWS. ETC ETC. EVERYONE has their eye on IonQ

NASDAQ2020

NASDAQ2020 18 minutes ago

Probably not our drug.
Our undisclosed CNS stimulant has overa Billion dollar market.

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions